SCS ASM 2025 would like to thank the following companies for their support:
A healthy heart and circulatory system are essential to good health. That’s why at Abbott, we throw our hearts into advancing treatments for people with cardiovascular disease. We focus on innovative technologies that can improve the way clinicians treat people with vascular diseases, irregular heartbeats and diseases of the heart’s valves and other structures. Visit www.cardiovascular.abbott for more information about technologies and solutions for treating cardiovascular conditions
(https://www.cardiovascular.abbott/us/en/hcp/products.html)
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines
(https://www.amgen.com.sg/)
At Menarini, we are dedicated to invigorating lives. Driven by a firm belief that good health empowers people to unlock their full potential, our cardiovascular portfolio strives to enhance healthcare and uplift the lives of people and communities.
(https://www.menariniapac.com/)
AstraZeneca is a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for the society and planet. CVRM (Cardiovascular, Renal and Metabolism) is a main therapy area and our ambition is to to slow or stop disease progression and improve outcomes in patients.
(https://www.astrazeneca.com/)
At Boehringer Ingelheim, we strive to improve the health of humans and animals – for generations. We work together with integrity and are guided by a shared purpose that defines who we are and what we do.
(https://www.boehringer-ingelheim.com/)
Bristol Myers Squibb is a global biopharmaceutical company that is focused on discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. It focuses on driving scientific and academic excellence while rigorously developing innovative, high-quality treatments to meet patient needs.
(https://www.bms.com/sg)
DKSH is a leading Market Expansion Services provider for healthcare companies in Asia Pacific and Switzerland. With nearly 160 years of experience, they offer integrated solutions including registration, marketing, sales, distribution, and more through their extensive network of healthcare outlets and developing channels.
(https://www.dksh.com/sg-en/home/healthcare)
At GSK, we combine science, technology, and talent to prevent and treat disease through specialty medicines and vaccines, focusing on respiratory, immunology, oncology, HIV, and infectious diseases. Our Ahead Together strategy aims to intervene early, changing disease outcomes and supporting healthcare systems.
(https://www.gsk.com/en-gb/locations/singapore/)
HTM Medico is the exclusive distributor of PulseOn in Singapore, offering advanced wrist-based heart rate monitoring designed for accurate arrhythmia and atrial fibrillation detection. With medical-grade precision and continuous tracking, PulseOn empowers healthcare professionals with reliable, real-time data for improved patient diagnosis and management. Elevate cardiac care with HTM Medico.
(https://www.htmmedico.com.sg/)
Medison is a global pharma company focused on providing access to highly innovative therapies in international markets, helping to save and improve the lives of patients suffering from the most challenging diseases.
(https://www.medisonpharma.com/)
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
(https://www.novartis.com/sg-en/)
Novo Nordisk is a leading global healthcare company established in 1923, with a legacy of over 100 years and a rich heritage in diabetes. The company specializes in innovative treatments for diabetes, obesity, and rare blood and endocrine diseases. Novo Nordisk is dedicated to addressing unmet medical needs, expanding medicine access, and committed to driving change to defeat serious chronic diseases.
(https://www.novonordisk.sg/)
At Organon, we are here for her health. Our goal is to be the leading women’s health company in the world by focusing on women’s everyday health needs.
Today, our company has a portfolio of over 60 medicines and products that we deliver to patients in ~140 markets around the world. But we know there is so much we can do to support the health of women. Therefore, we will put women at the center of everything we do, striving to listen and understand her healthcare needs, big and small, to ensure we provide medicines and other products that allow her to live a better and healthier every day.
(https://www.organon.com/singapore/)
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products.
(https://www.pfizer.com.sg/)
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
(https://www.sanofi.com/en/singapore)
At Servier, our independence empowers us to make strategic, long-term decisions for patient care. We prioritize collaboration with healthcare professionals, innovate with them, and consider our social and environmental impact. Together, we’re building the future of healthcare.
(https://servier.com/en/servier/)
In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life.
Viatris’ name is rooted in Latin and embodies a vision of providing a path (“VIA”) to three (“TRIS”) critical goals: expanding access to medicines, leading by innovating to meet patient needs, and being a trusted partner for the healthcare community worldwide.
We produce medicines for patients across a broad range of major therapeutic areas, spanning both noncommunicable and infectious diseases.We provide access to our of high-quality medicines in more than 165 countries and territories.
(https://www.viatris.com/en)
Registration info
Secure your spot and join leading experts in cardiology from around the globe. Early registration offers the best rates and access to a wealth of networking opportunities, expert sessions, and more. Registration opens Soon!
Venue Info
Our 2025 venue will be the luxurious Grand Copthorne Waterfront Hotel in Singapore. With its state-of-the-art conference facilities and stunning riverside views, the venue promises an inspiring and memorable setting for all attendees.
SUBMIT YOUR ABSTRACT
Showcase your research by submitting your abstract! Share your latest findings with an engaged audience of peers and experts, gain valuable feedback, and contribute to advancing the field of cardiology. Submit opens soon!